Targeting PAR2 Overcomes Gefitinib Resistance in Non-Small-Cell Lung Cancer Cells Through Inhibition of EGFR TransactivationYuhong Jiang, Canquan Mao|Frontiers in Pharmacology|2021Cited by 24